Personas / Equipo Humano

Lourdes Ibañez Toda

Buscador de publicaciones

Publicaciones

  • Murphy R, Ibañez-Toda L, Hattersley A and Tost J.

    IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance

    BMC MEDICAL GENETICS . 13: 42-42. Nº de citas: 23

    [doi:10.1186/1471-2350-13-42]

  • de Zegher F, Díaz-Silva M, Sebastiani G, Martín-Ancel A, Sánchez-Infantes D, López-Bermejo A and Ibañez-Toda L.

    Abundance of Circulating Preadipocyte Factor 1 in Early Life

    Diabetes Care . 35(4): 848-849. Nº de citas: 29

    [doi:10.2337/dc11-1990]

  • López ID, Muñoz Ade A, Muñoz JB, Rodríguez PC, Gómez EG, Ollero MJ, Rodríguez JM, Dehlia AC, Estrada RC and Ibañez-Toda L.

    [Follow-up of the small-for-gestational-age child: clinical guidelines].

    ANALES DE PEDIATRIA . 76(2): 1041-7. Nº de citas: 3

    [doi:10.1016/j.anpedi.2011.08.003]

  • Sebastiani G, Díaz-Silva M, López-Bermejo A, Arranz A, de Zegher F and Ibañez-Toda L.

    Circulating follistatin in the human foetus at term birth

    PEDIATRIC OBESITY . 7(1): 39-43. Nº de citas: 7

    [doi:10.1111/j.2047-6310.2011.00004.x]

  • Osiniri I, Sitjar C, Soriano-Rodríguez P, Prats-Puig A, Casas-Satre C, Mayol L, de Zegher F, Ibañez-Toda L, Bassols J and López-Bermejo A.

    Carotid Intima-Media Thickness at 7 Years of Age: Relationship to C-Reactive Protein Rather than Adiposity

    JOURNAL OF PEDIATRICS . 160(2): 276-323. Nº de citas: 12

    [doi:10.1016/j.jpeds.2011.07.020]

  • Marín-del Barrio S, Casano-Sancho P, Villarreal-Peña N, Sebastiani G, Pinillos S, Pérez-Dueñas B, Hwa V, Rosenfeld RG and Ibañez-Toda L.

    Triple A Syndrome in a Patient with Genetic Growth Hormone Insensitivity: Phenotypic Effects of Two Genetic Disorders

    HORMONE RESEARCH IN PAEDIATRICS . 77(1): 63-68. Nº de citas: 9

    [doi:10.1159/000335235]

  • Vinaixa M, Rodriguez MA, Samino S, Díaz-Silva M, Beltran A, Mallol R, Bladé C, Ibañez-Toda L, Correig X and Yanes O.

    Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy

    PLoS One . 6(12): . Nº de citas: 55

    [doi:10.1371/journal.pone.0029052]

  • Bassols J, Prats-Puig A, Soriano-Rodríguez P, García-González MM, Reid J, Martínez-Pascual M, Mateos-Comerón F, de Zegher F, Ibañez-Toda L and López-Bermejo A.

    Lower Free Thyroxin Associates with a Less Favorable Metabolic Phenotype in Healthy Pregnant Women

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 96(12): 3717-3723. Nº de citas: 72

    [doi:10.1210/jc.2011-1784]

  • Lázaro I, Díaz-Silva M, Cabré A, Masana L and Ibañez-Toda L.

    Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess

    GYNECOLOGICAL ENDOCRINOLOGY . 27(11): 935-939. Nº de citas: 12

    [doi:10.3109/09513590.2011.569608]

  • Ibañez-Toda L, Díaz-Silva M, Sebastiani G, Sánchez-Infantes D, Salvador C, Lopez-Bermejo A and de Zegher F.

    Treatment of Androgen Excess in Adolescent Girls: Ethinylestradiol-Cyproteroneacetate Versus Low-Dose Pioglitazone-Flutamide-Metformin

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 96(11): 3361-3366. Nº de citas: 31

    [doi:10.1210/jc.2011-1671]